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A series of four substituted benzo[g]quinoxaline species have been synthesised and utilised as cyclo-
metalating ligands for iridium(III). The ligands (L1-L4) were synthesised and isolated in good yield
following the condensation of 2,3-diaminonaphthalene with benzil and three of its derivatives. The
substituent modulated electronic properties of L1-L4 were dominated by intraligand pp* transitions,
with the ﬂuorescence proﬁle demonstrating vibronic features attributed to the highly conjugated nature
of the chromophore. Iridium(III) complexes of the form [Ir(L)2(bipy)]PF6 were synthesised from L1-L4 in
two steps. The electronic properties of the complexes reveal absorption in the UV-vis. region with spin
forbidden metal-to-ligand charge transfer (MLCT) transitions possibly contributing at longer wave-
lengths to ca. 600 nm. Steady state luminescence (aerated, room temperature) on solutions of the
complexes showed dual emissive properties in the visible and near-infra red (NIR) regions. Firstly, a
vibronically structured emission in the visible region (ca. 525 nm) was attributed to ligand centred
ﬂuorescence (lifetime < 10 ns). Secondly, a broad emission peak in the NIR (ca. 950 nm) which extended
to around 1200 nmwas observed with corresponding lifetimes of 116e162 ns, indicative of triplet excited
state emission.
© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The development and study of molecular species that are
luminescent in the near-infra red (NIR) region continues to attract
signiﬁcant attention. Such studies have been motivated by the
many applications (some postulated, others realised) that can
beneﬁt from NIR luminescent materials [1]. A range of optoelec-
tronic devices can utilise NIR wavelengths. In the realm of bio-
imaging, it has long been argued that the use of ﬂuorescence
microscopy as a research and diagnostic tool can greatly beneﬁt
from the use of NIR excitation and emission wavelengths [2]. The
optical properties of biological tissue are such that its relative
transparency in parts of the NIR region can greatly improve optical
imaging potential. Achieving NIR luminescence from molecular
species has therefore become an ongoing challenge. From aeames), popesj@cardiff.ac.uk
r B.V. This is an open access articlphotophysical perspective, consideration of the nature of the
excited emitting state and suppression of non-radiative deactiva-
tion pathways (particularly where the energy gap between the
ground and excited state is small) is a key challenge.
Lanthanide coordination compounds have been successfully
developed in this regard with Nd(III), Er(III) and Yb(III) species
demonstrating long-lived emission in the 880e1550 nm window
[3]. Uniquely, such species possess metal centred (4f) excited states
that can give rise to NIR emission. Whilst demonstrating attractive
emission properties, the limiting aspect of such systems is over-
coming the inherently poor molar absorption coefﬁcients associ-
ated with 4f-4f transitions [4]. Over the last two decades a wide
range of functionalised ligand systems have been developed to
address these challenges [5].
In contrast, only a relatively small number of reports have
described NIR emission from d-metal complexes. Most commonly
such observations are often deﬁned at low temperature (i.e. in a
frozen matrix) or under deoxygenated conditions. Of course, both
approaches seek to minimise non-radiative quenching of the
excited emitting state. For several decades, Cr(III) complexes havee under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
K.A. Phillips et al. / Journal of Organometallic Chemistry 893 (2019) 11e2012been known to demonstrate emission from a d-centred excited
state (2E) which typically emits around 780 nm, and work con-
tinues to maximise these properties [6]. A small number of Ru(II)
[7], Os(II) [8], and Pt(II) [9] complexes have also been reported to
demonstrate luminescence in the NIR region. Strategies can include
lowering the energy of charge transfer (CT) excited states or facil-
itating the population of low-lying ligand-centred triplet states
through efﬁcient spin orbit coupling (SOC) facilitated by the heavy
metal atom of the complex.
Cyclometalated Ir(III) complexes have also, very recently, been
investigated in this context. Neutral Ir(III) complexes based on 1-
(benzo[b]thiophen-2-yl)-isoquinolinate show emission between
680 and 850 nm and have been successfully processed into phos-
phorescent organic light-emitting devices [10]. Ir(III) complexes
with boron-dipyrromethane (BODIPY) conjugated ligands have
shown interesting NIR absorption and emission properties with
particularly long triplet state lifetimes [11]. Wong and co-workers
have demonstrated highly tuneable emission properties for Ir(III)
complexes using both conjugation and substitution strategies on
the cyclometalating ligands [12]. This has allowed the emission to
be tuned in the range 420e729 nm with successful application
shownwithin light emitting diodes. Two further reports of cationic
Ir(III) complexes that incorporate benzo[g]quinoxaline cyclo-
metalated ligands have been previously described by Chen et al.
[13] and Sun and co-workers [14]. The extended conjugation of
these ligands, versus the red wavelength emission observed from
previous studies on 2-phenylquinoxaline analogues [15], appears to
bathochromically shift the emission wavelength into the NIR re-
gion. Building on these reports, we herein describe a further series
of Ir(III) organometallic complexes based on substituted benzo[g]
quinoxaline ligands, providing further evidence that these species
are viable NIR emitters, even under ambient conditions (room
temperature, aerated solution).Fig. 1. X-ray crystal structure of L3. Ellipsoids are drawn at a 50% probability. Crystal
Data: C24H14Br2N2, Mr¼ 490.19, monoclinic, P21/n (No. 14), a¼ 5.7963(2) Å,
b¼ 21.8021(9) Å, c¼ 15.1661(6) Å, b¼ 91.211(3) , a¼ g¼ 90 , V¼ 1916.15(13) Å3,
T¼ 100(2) K, Z¼ 4, Z’¼ 1, m(MoKa)¼ 4.243mm1, 19907 reﬂections measured, 4396
unique (Rint¼ 0.0501) which were used in all calculations. The ﬁnal wR2 was 0.1219 (all
data) and R1 was 0.0491 (I> 2(I)).2. Results and discussion
2.1. Synthesis and characterisation
The ligands (L1-L4) were synthesised in a single step by the
condensation reaction of 2,3-diaminonaphthalene with a benzil
derivative in the presence of acetic acid. The ligands (Scheme 1)
were isolated in good yield and characterised using a range of
analytical and spectroscopic techniques. All relevant data is pre-
sented in the experimental section. Good quality single crystalsScheme 1. The benzo[g]quinoxaline ligands synthesised in this study for Ir(III)
complexation.were obtained for the dibromo-substituted derivative L3 following
slow evaporation of a concentrated chloroform solution. The or-
ange blade shaped crystals were submitted to diffraction studies
and the structure was reﬁned in the P21/n space group and there is
a single molecule in the asymmetric unit. The data conﬁrmed the
proposed structure (Figs. 1 and 2), with a packing arrangement
supported by some long range intermolecular p-p interactions.
The complexes (Scheme 2) were synthesised according to the
well known Nonoyama route [16] that ﬁrst isolates the chloro-
bridged dimeric Ir(III) species, [(L)2Ir-(m-Cl2)-Ir(L)2]. Subsequent
splitting of the dimer with 2,20-bipyridine gave the target cationic
complexes. HRMS data was obtained for each of the complexes and
showed the correct isotopic distribution in all cases (Fig. 3). In
addition to this, 1H NMR spectroscopy was particularly insightful
for the determination of the coordination of the ligands to the
iridium centre. This was typically noted by the upﬁeld shift of theFig. 2. Packing diagram for L3 obtained from the X-ray crystal structure. Ellipsoids are
drawn at a 50% probability.
Scheme 2. The structures of the iridium(III) complexes synthesised in this study.
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Fig. 4). In the 1H NMR spectra of [Ir(L2)2(bipy)]PF6 and [Ir(L4)2(-
bipy)]PF6, there were two unique methyl environments (note that
they are equivalent in the free ligand) indicative of cyclometalation
in the expectedmanner (i.e. the benzo[g]quinoxaline ligands do not
act in a bridging manner). The frequency separations in these
inequivalent methyl resonances was approximately 0.5 ppm.
2.2. UV-vis. and luminescence spectroscopy
The solution state absorption spectra of the ligands L1-L4
(Fig. 5) were recorded as chloroform solutions at 1 105M and
were comparable to related literature examples that are based on
the benzo[g]quinoxaline chromophore [11e13]. All ligands showed
strong (ε> 104M1cm1) pep* transitions in the UV region at
200e400 nm. A shoulder feature extended beyond 450 nm but
again is attributed to low energy pep* transitions although weaker
nep* transitions may also contribute in this region. The phenyl
substituent (-H, -Me, -Br, -OMe) of the ligand clearly inﬂuences the
positioning of these bands, with the methoxy substituted L4possessing the most bathochromically shifted features, which was
attributed to the increased conjugation induced by the -OMe sub-
stituents. The corresponding emission spectra obtained for these
ligands shows that they are all luminescent in the visible region
from 400 to 550 nm showing some vibronic structure to the peak
shape. Again the nature of the substituent inﬂuences the peak
positioning, and in this case the benzil derivative (L1) possesses the
longest emission wavelength. The recorded lifetimes for each
ligand were found to be< 5 ns, consistent with ﬂuorescence from a
1pep* emitting state.
UV-vis. spectroscopy on solutions of the complexes revealed
spectra with multiple contributions across the UV and visible re-
gions (Fig. 6; Table 1). The majority of peaks at wavelengths than
250e450 nm are attributed to different ligand-centred transitions
that are perturbed upon coordination to the Ir(III) centre, as well as
contributions from spin allowed metal-to-ligand charge transfer
bands (1MLCT).
The ancillary bipyridine ligand pep* absorptions are also likely
to contribute ca. 270e290 nm. When compared to the ligand
spectra, each of the complexes showed additional absorption bands
Fig. 3. Example of a high resolution mass spectrum obtained for [Ir(L3)2(bipy)]PF6 showing the cationic fragment (main) and observed versus theoretical isotopic distribution
pattern (inset).
Fig. 4. 1H NMR spectrum of [Ir(L1)2(bipy)]PF6 that shows the upﬁeld shift of the ligand proton adjacent to the cyclometalating carbon atom.
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absorption bands may comprise spin forbidden 3MLCT bands [17].
These Ir(III) complexes therefore demonstrate strong bathochromic
shifts in the visible region relative to related complexes based upon
substituted 2-phenylquinoxaline ligands [15]. This is attributed tothe lowering of the MLCT transitions due to the added conjugation
of the ligand benzo[g]quinoxaline ligands. The subtle variation
between the complexes are again indicative of the electronic
character of the substituents; as with the free ligands the methoxy-
substituted variant [Ir(L4]2(bipy)]PF6 possessed the lowest energy
Fig. 5. UVevis absorption (left) and emission (right) spectra of the ligands (105M CHCl3).
Fig. 6. UVevis absorption spectra of the complexes (105M CHCl3; C1¼ [Ir(L1]2(bipy)]
PF6, C2¼ [Ir(L2]2(bipy)]PF6, C3¼ [Ir(L3]2(bipy)]PF6, C4¼ [Ir(L4]2(bipy)]PF6).
Fig. 7. Visible emission spectra for the complexes (aerated CHCl3, lexc¼ 405 nm;
C1¼ [Ir(L1]2(bipy)]PF6, C2¼ [Ir(L2]2(bipy)]PF6, C3¼ [Ir(L3]2(bipy)]PF6, C4¼ [Ir(L4]2(-
bipy)]PF6).
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The luminescence spectra for the complexes were recorded on
aerated samples at room temperature (Table 1). In all cases an
excitation wavelength of 470 nm was used as this corresponds to
strong absorption bands in all of the complexes reported herein.
The ﬁrst collection of emission spectra were recorded between 490
and 750 nm and revealed a deﬁned vibronic progression to the
peak shape that was reproduced for each of the four complexes, but
differentiated from the corresponding free ligands (Fig. 7). In fact
these emission spectra for the complexes are virtually superim-
posable, with little variance in the wavelength positioning of theseTable 1
Absorption and emission data for the ligands and complexes.a Recorded in aerated CHCl
Compound labs/nm[a]
L1 386, 309, 276
L2 391, 323, 312, 276
L3 393, 318, 280
L4 402, 332, 319, 276
[Ir(L1)2(bipy)]PF6 554sh, 490, 415, 329, 286
[Ir(L2)2(bipy)]PF6 554sh, 491, 445, 420, 388, 367, 334, 283
[Ir(L3)2(bipy)]PF6 554sh, 500, 439, 415, 340, 287
[Ir(L4)2(bipy)]PF6 554sh, 455, 348, 285bands across the series. Time-resolved measurements provided the
emission lifetimes for the visible emission which were all short-
lived (<10 ns). Taken together the data implies that these features
may be due to intraligand transitions associated with the coordi-
nated phenyl benzo[g]quinoxaline units (see further discussion in
computational section).3;b lexc¼ 405 nm;c lexc¼ 295 nm;d lexc¼ 505 nm;e lexc¼ 355 nm.
lem/nm[a,b] (t/ns[c]) lem/nm[a,d] (t/ns[e])
485 (1.4) e
480 (1.1) e
490 (1.8) e
480 (1.1) e
520 (4.9) 915 (119)
520 (7.0) 912 (148)
520 (2.9) 928 (116)
520 (<1) 949 (162)
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luminescence properties of closely related 2-phenylquinoxaline
complexes of Ir(III), which we have previously described [15],
which were shown to be phosphorescent around 620e650 nm and
attributed to a 3MLCT emitting state. Therefore, further lumines-
cence studies on the complexes investigated the possibility of
emission in the NIR region. Again, aerated solutions were studied at
room temperature and, using an excitation wavelength of 505 nm,
spectra were collected between 850 and 1300 nm.
As shown in Fig. 8, under these conditions, each of the com-
plexes demonstrated luminescence in the NIR region peaking
around 915e950 nm. The appearance of the emission peak is very
broad and tails to ca.1250 nm. This is consistent with the ﬁndings of
previous work on related complex structures using different benzo
[g]quinoxaline based ligands [12,13]. Each of the spectra includes an
additional sharp emission peak centred at 1274 nm which is char-
acteristic of the radiative decay that accompanies the spin
forbidden relaxation of singlet oxygen (1O2 / 3O2). The photo-
generation of singlet oxygen in solution, ﬁrstly corroborates the use
of aerated solvent for the measurements, and secondly, implies the
presence of an excited triplet state on a sensitizer molecule.
Further, time-resolved measurements monitoring the decay ki-
netics of the NIR emission band revealed emission lifetimes in the
range of 116e162 ns, each indicative of a triplet excited state.
Critically, these lifetimes are signiﬁcantly longer than those
attributed to the visible emission of the complexes (measured
under identical sample conditions).
2.3. Density functional theory (DFT) calculations
The geometries of all the complexes were optimised in
Gaussian09 using the B3LYP functional with a combination of 6-
31G* basis sets for the ligand atoms and the Stuttgart-Dresden
(SDD) core potential/basis set for the iridium metal core [18]. Sol-
vent effects were included implicitly using the self-consistent re-
action ﬁeld (SCRF) and polarized continuum (IEFPCM) models.
Time dependent DFT (TD-DFT) calculations were performed on the
stationary points to determine the ﬁrst ﬁve singlet excited states for
each complex, using the same basis sets and the long range cor-
rected CAM-B3LYP functional. Phosphorescence and spin forbidden
absorption bands were computed using unrestricted DFT calcula-
tions, computing parameters for the ﬁrst triplet state of the com-
plexes (T1). Fig. 8 shows the superimposition of the calculatedFig. 8. Steady state near-IR emission spectra of the complexes. The peak at 1274 nm is
due to the photogeneration of, and subsequent emission from, 1O2. (Aerated CHCl3,
lexc¼ 505 nm; C1¼ [Ir(L1]2(bipy)]PF6, C2¼ [Ir(L2]2(bipy)]PF6, C3¼ [Ir(L3]2(bipy)]PF6,
C4¼ [Ir(L4]2(bipy)]PF6).molecular geometries of the complexes in both singlet and triplet
excited states. Whilst the geometries look broadly similar it is
notable that there are differing degrees of distortion within the
coordinated ligand fragments of the two excited states. The
composition of the complexes’ HOMOs and LUMOs are detailed in
Table 2.
In all cases the cyclometalated ligands are predicted to
contribute strongly to bothmolecular orbitals, with Ir contributions
of 13e26% for the HOMO. Orbital contributions to the excited states
(see ESI) show that a range of transitions are predicted for each. The
lowest calculated energy excited state is dominated by the HOMO
/ LUMO transition, which may comprise both MLCT and intra(-
cyclometalated)ligand contributions (Table 2). It is noteworthy that
the DFT calculations suggest that bipyridine localised orbitals pri-
marily contribute to the upper lying LUMOþ2 and LUMOþ3,
neither of which feature strongly as participants in contributing
transitions to the predicted excited states. Ligand centred transi-
tions, more speciﬁcally transitions localised on the benzo[g]qui-
noxaline ligands, are assigned as the dominant contributors to the
visible complex emission. This is consistent with the similarity in
vibronic band shapes between the free ligand emission (Fig. 2) and
the complex emission band (Fig. 3). Both of these emission bands
show clear vibrational progressions, with a vibrational spacing of
~1300 cm1. This vibrational frequency is consistent with quinox-
alene (predominantly pyrazine) ring breathing modes, which are
the most infrared active modes for these ligands. The electronic
emission spectrum of the free ligand has been simulated using the
Franck-Condon-Herzberg-Teller approach implemented in the
Gaussian09 software package [19,20]. Both ground and excited
states have been optimised using the DFT//B3LYP/6-31G(d)
method, with the excited state being optimised using TD-DFT.
The Franck-Condon progression has then been calculated using
the vibrational frequencies from the two states, at a temperature of
300 K, and convoluted with a HWHM of 500 cm1. The computed
spectrum is shown below (Fig. 9) in comparison with the experi-
mental spectra of the free ligand L1, and the complex [Ir(L1]2(bipy)]
PF6.
The spectra shown in Fig. 9 show remarkable agreement be-
tween simulation and experiment. The simulated spectrum has
been deliberately slightly under convoluted to highlight the overlap
of the vibronic peak positions. This agreement not only conﬁrms
the assignment of the vibronic features, but further illustrates the
similarity between L1within the complex [Ir(L1]2(bipy)]PF6 and as
its free ligand. The vibrational spacing is approximately consistent
between the free ligand and the complex, but there is a clear
change in the Franck-Condon factors associated with the progres-
sion. This is equally consistent with the assignment: the metal
binding to the ligand alters the bond lengths of the pyrazine ring,
slightly lengthening the C-N bonds (C]N,1.315 Å; C-N,1.37 Å in the
free ligand, C]N, 1.347 Å; C-N, 1.39 Å in the complex) which will
alter the Franck-Condon overlap between S0 and S1.
Further photochemical properties of the complexes have alsoTable 2
Predicted MO compositions of the HOMO and LUMO of the complexes.
Compound [a] Ir (5d) C^N (1) C^N (2) bipy
HOMO
[Ir(L1)2(bipy)]PF6 26% 36% 36% 1%
[Ir(L2)2(bipy)]PF6 26% 37% 36% 1%
[Ir(L3)2(bipy)]PF6 13% 44% 42% 0%
[Ir(L4)2(bipy)]PF6 16% 40% 43% 1%
LUMO
[Ir(L1)2(bipy)]PF6 3% 48% 47% 1%
[Ir(L2)2(bipy)]PF6 3% 47% 48% 2%
[Ir(L3)2(bipy)]PF6 3% 49% 46% 3%
[Ir(L4)2(bipy)]PF6 3% 47% 49% 2%
Fig. 9. Franck-Condon simulation of the L1 A-X transition (blue), overlaid against the
experimental emission spectra of the free ligand L1 (red), and the complex [Ir(L1]2(-
bipy)]PF6 (black). The spectra have been offset by their respective vibronic origin, and
are therefore displayed as emission energy (cm1) relative to zero. The grey bars are a
guide to the eye, showing different vibronic features. (For interpretation of the refer-
ences to colour in this ﬁgure legend, the reader is referred to the Web version of this
article.)
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are shown in Table 3, including those that are spin forbidden and
thus relate to an excitation (T1 ) S0, at S0 minimum energy ge-
ometry) and phosphorescence (T1 / S0, at T1 minimum energy
geometry). The overlap between the S1 and T1 minimum energy
geometries are highlighted in Fig. 10. The calculated dataFig. 10. A comparison of the calculated geometries of the singlet and triplet excited states for
Table 3
Calculated vertical transitions for the complexes.
Compound S1) S0/nm T1) S0/nm T1/ S0/nm
[Ir(L1)2(bipy)]PF6 433 557 993
[Ir(L2)2(bipy)]PF6 434 602 980
[Ir(L3)2(bipy)]PF6 428 590 1019
[Ir(L4)2(bipy)]PF6 428 583 962corresponds well with the experimental results and importantly
predicts that the emission should occur in the NIR region around
962e1019 nm. Both the spin allowed and spin forbidden excitations
correlate well with the primary features of the complexes’ ab-
sorption spectra. The DFT results suggest that the variations in
ligand structure induce differences in emission energy, but these
subtleties were not apparent in the broadened features of the
experimental data. It is also intriguing to see that such subtle
changes in geometry within the triplet state, i.e. geometric relax-
ation after ISC, lead to dramatic changes in the T1 e S0 energy gap.
Tempering or expanding upon this shift will form the basis of future
work.
3. Conclusion
Extending the conjugation of cyclometalating ligands on iri-
dium(III) can bathochromically shift luminescence from organo-
metallic complexes into the NIR spectral region. For Ir(III),
substituted benzo[g]quinoxaline type cyclometalting ligands are
appropriate choices to achieve this and the study shows that sup-
porting DFT calculations can reliably predict the spin forbidden
transitions that dominate the lowest energy absorptions and
phosphorescent emission properties of these complexes.
4. Experimental
All reactions were performed with the use of vacuum line and
Schlenk techniques. Reagents were commercial grade and were
used without further puriﬁcation. 1H and 13C{1H} NMR spectra
were run on NMR-FT Bruker 400 or 250 spectrometers and recor-
ded in CDCl3. 1H and 13C-{1H} NMR chemical shifts (d) were
determined relative to internal TMS and are given in ppm. Low-
resolution mass spectra were obtained by the staff at Cardiff Uni-
versity. High-resolution mass spectra were carried out by at the
EPSRC National Mass Spectrometry Service at Swansea University.
UV-Vis studies were performed on a Jasco V-570 spectrophotom-
eter as MeCN solutions (105M). Photophysical data were obtained
on a JobinYvon-Horiba Fluorolog spectrometer ﬁtted with a JY TBX
picosecond photodetection module as MeCN solutions. A Hama-
matsu R5509-73 detector (cooled to80 C using a C9940 housing)
was used for NIR luminescence measurements. For the NIR life-
times the pulsed laser source was a Continuum Minilite Nd:YAG[Ir(L3)2(bipy)]PF6 (left, RMSD¼ 0.185 Å) and [Ir(L4)2(bipy)]PF6 (right, RMSD¼ 0.149 Å).
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band pass ﬁlter was used. The pulsed source was a Nano-LED
conﬁgured for 295 nm output operating at 1MHz. All lumines-
cence lifetime proﬁles were obtained using the JobinYvon-Horiba
FluoroHub single photon counting module and the data ﬁts yiel-
ded the lifetime values using the provided DAS6 deconvolution
software.
4.1. Data collection and processing
X-ray diffraction datasets were measured on a Rigaku AFC12
diffractometer equipped with enhanced sensitivity (HG) Saturn
724 þ CCD detector mounted at the window of an FR-
E þ SuperBright rotating anode generator (Mo Ka, l¼ 0.71075 Å)
with VHF Varimax optics (70 mm focus) [21] using CrysAlisPro
software [22] for data collection and reduction.
4.2. Structure analysis and reﬁnement
The structures were solved by direct methods using Superﬂip
[23] and reﬁned on Fo2 by full-matrix least-squares reﬁnements
using SHELXL [24] within the OLEX2 suite [25]. All non-hydrogen
atoms were reﬁned with anisotropic displacement parameters,
and all hydrogen atoms were added at calculated positions and
reﬁned using a riding model with isotropic displacement parame-
ters based on the equivalent isotropic displacement parameter
(Ueq) of the parent atom.
4.3. Density functional theory
The geometries of all the complexes were optimised in
Gaussian09 using the B3LYP functional with a combination of 6-
31G* basis sets for the ligand atoms and the Stuttgart-Dresden
(SDD) core potential/basis set for the iridium metal core [16]. Sol-
vent effects were included implicitly using the self-consistent re-
action ﬁeld (SCRF) and polarized continuum (IEFPCM) models, and
in all cases the solvent chosen was chloroform, characterised by an
electrical permittivity of ε¼ 4.7113. Molecular orbital calculations
were performed using the same basis sets and functionals, and
decomposition analysis was performed on the frontier orbitals
using the GaussSum software package. TD-DFT calculations were
performed on the stationary points to determine the ﬁrst ﬁve
singlet excited states for each complex, using the same basis sets
and the long range corrected CAM-B3LYP functional. Phosphores-
cence and spin forbidden absorption bands were computed using
unrestricted DFT calculations, computing parameters for the ﬁrst
triplet state of the complexes (T1). The Franck-Condon simulations
were performedwithout implicit solvation, however it is clear from
the agreement between experiment and theory that this does not
signiﬁcantly alter the results. Additionally, the Franck-Condon
progressions are harmonic in nature. Small shifts in peak posi-
tions would be expected using anharmonic modes (the harmonic
scaling factor for this functional and basis set is ca.0.962) [26],
however these shifts are expected to be small relative to the peak
widths. The Chimera software package was used to visualise the
complexes and compare singlet and triplet geometries [27].
4.4. Synthesis
4.4.1. Synthesis of 2,3-diphenylbenzo[g]quinoxaline (L1)
To a stirred solution of benzil (322mg, 1.6mmol) in ethanol
(15mL) was added 2,3-diaminonaphthalene (250mg, 1.6mmol)
and acetic acid (0.5mL). The reaction mixture was heated at reﬂux
under a nitrogen atmosphere for 24 h. The reaction mixture was
cooled to room temperature and a precipitate collected by ﬁltrationto give L1 as a brown solid (0.34 g, 64%). 1H NMR (300MHz, CDCl3):
dH 8.68 (s, 2H, CH), 8.05 (dd, J¼ 3.21 Hz, 6.39 Hz, 2H), 7.50 (m, 6H),
7.30 (m, 6H) ppm. 13C{1H} NMR (101MHz, CDCl3): dC 154.2, 139.2,
138.0, 134.1, 129.8, 129.0, 128.6, 128.3, 127.6, 126.8 ppm. HRMS
found m/z 333.1387; calcd m/z 333.1386 for C24H16N2. UV-vis.
(CHCl3) lmax (ε/dm3 mol1 cm1): 386 (25200), 309 (71500), 276
(114100) nm. Selected IR (solid) ymax¼ 1607, 1508, 1441, 1346, 1248,
1175, 1013, 976, 876, 836, 760, 741, 691, 552, 500.0, 490, 467 cm1.
4.4.2. Synthesis of 2,3-di-p-tolylbenzo[g]quinoxaline (L2)
As L1 but with 4,40-dimethylbenzil (376mg, 1.6mmol) and 2,3-
diaminonaphthalene (250mg, 1.6mmol). Product collected as a
brown solid (0.41 g, 71%). 1H NMR (300MHz, CDCl3) dH 8.73 (s, 2H),
8.12 (dd, J¼ 3.2, 6.5 Hz, 2H), 7.57 (dd, J¼ 3.1, 6.7 Hz, 2H), 7.49 (d,
J¼ 8.0 Hz, 4H), 7.19 (d, J¼ 8.0 Hz, 4H), 2.41 (s, 6H) ppm. 13C{1H}
NMR (101MHz, CDCl3) dC 154.3, 139.0, 138.0, 136.5, 134.0, 129.8,
129.0, 128.6, 127.4, 126.6, 21.4 ppm. HRMS m/z found 361.1699;
calcdm/z 316.1699 for C26H20N2. UV-vis. (CHCl3) lmax (ε/dm3 mol1
cm1): 391 (24800), 323 (48600), 312 (54200), 276 (134500) nm.
Selected IR (solid) ymax¼ 1607, 1508, 1445, 1346, 1247, 1174, 1109,
1013, 972, 878, 835, 819, 760, 559, 500, 490, 471, 421 cm1.
4.4.3. Synthesis of 2,3-bis(4-bromophenyl)benzo[g]quinoxaline
(L3)
As L1 but with 4,40-dibromobenzil (581mg, 1.6mmol) and 2,3-
diaminonaphthalene (250mg, 1.6mmol). Product collected as a
light brown solid (0.56 g, 72%). 1H NMR (400MHz, CDCl3) dH 8.66 (s,
2H), 8.05 (dd, J¼ 3.2, 6.5 Hz, 2H), 7.52 (m, 2H), 7.46 (d, J¼ 8.4 Hz,
4H), 7.38 (d, J¼ 8.4 Hz, 4H) ppm. 13C{1H} NMR (101MHz, CDCl3) dC
152.6, 137.9, 137.8, 134.3, 131.7, 131.4, 128.6, 127.7, 127.0, 123.9 ppm.
HRMS found m/z 490.9569; calcd m/z 490.9576 for C24H15Br2N2.
UV-vis. (CHCl3) lmax (ε/dm3mol1cm1): 393 (11400), 318 (34300),
280 (46400) nm. Selected IR (solid) ymax¼ 1605, 1510, 1445, 1344,
1246, 1173, 1109, 1053, 1011, 972, 880, 833, 795, 758, 745, 723, 656,
646, 623, 573, 557, 548, 532, 498, 471, 409 cm1.
4.4.4. Synthesis of 2,3-bis(4-methoxyphenyl)benzo[g]quinoxaline
(L4)
As L1 but with anisil (427mg, 1.6mmol) and 2,3-
diaminonaphthalene (250mg, 1.6mmol). Product collected as a
light brown solid (0.50 g, 80%). 1H NMR (300MHz, CDCl3) dH 8.61 (s,
2H, CH), 8.02 (dd, J¼ 3.01, 6.42 Hz, 2H), 7.48 (d, J¼ 8.31 Hz, 6H),
6.83 (d, J¼ 8.43, 4H), 3.78 (s, 6H) ppm. 13C{1H} (101MHz, CDCl3) dC
160.4, 153.8, 138.0, 133.9, 131.8, 131.3, 128.5, 127.2, 126.5, 113.8,
55.4 ppm. HRMS found m/z 393.1593; calcd m/z 392.1598 for
C26H21N2O2. UV-vis. (CHCl3) lmax (ε/dm3mol1cm1): 402 (16900),
332 (24200), 319 (25600), 276 (110300) nm. Selected IR (solid)
ymax¼ 1605, 1578, 1541, 1508, 1445, 1414, 1344, 1275, 1246, 1173,
1109, 1051, 1015, 976, 891, 880, 853, 833, 795, 756, 747, 656, 646,
623, 592, 573, 557, 532, 525, 496, 474, 421 cm1.
4.5. Synthesis of complexes
Synthesis of [Ir(C^N)2Cl2]2 IrCl3. xH2O (1 eq.) and ligand, L (2 eq.)
were dissolved in 2-ethoxyethanol (10mL) and the reaction
mixture heated at reﬂux for 48 h. The reaction was then cooled to
room temperature and water (30mL) was added to form a dark
brown precipitate. The solid was collected by ﬁltration to yield
[(L)2Ir(m-Cl2)Ir(L)2].
4.5.1. Synthesis of [Ir(L1)2(bipy)][PF6]
[(L1)2Ir(m-Cl2)Ir(L1)2] (195mg, 0.11mmol) and 2,20-bipyridyl
(36mg, 0.23mmol) were dissolved in 2-ethoxyethanol (10mL) and
heated at reﬂux for 24 h under a nitrogen atmosphere. The reaction
mixture was then cooled to room temperature and a saturated
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Upon formation of a red precipitate, the mixture was ﬁltered and
the precipitate washed with water and diethyl ether. The crude
solid was puriﬁed by column chromatography using DCM followed
by DCM/MeOH (9:1). Product collected as ﬁrst red band with DCM/
MeOH and dried in vacuo to give [Ir(L1)2(bipy)][PF6] as a red solid
(38mg, 15%). 1H NMR (400MHz, CDCl3) dH 8.65 (d, J¼ 5.6 Hz, 2H),
8.55 (s, 2H), 8.31 (d, J¼ 8.8 Hz, 2H), 8.12 (app. t, J¼ 8.8 Hz, 2H), 7.91
(d, J¼ 8.4 Hz, 2H), 7.89e7.77 (m, 6H), 7.75 (s, 2H), 7.64e7.60 (m, 6H),
7.44 (app. t, J¼ 8.8 Hz, 2H), 7.36 (app. t, J¼ 6.4 Hz, 2H), 7.17 (s, 2H),
6.98 (d, J¼ 8.8 Hz, 2H), 6.70 (app. t, J¼ 5.6 Hz, 2H), 6.61 (app. t,
J¼ 7.2 Hz, 2H), 6.50 (d, J¼ 7.2 Hz, 2H) ppm. 13C{1H} NMR (101MHz,
CDCl3) dC 164.5, 155.8, 154.3, 153.8, 147.9, 144.3, 139.6, 134.6, 133.7,
132.5, 131.5, 130.4, 129.4, 129.4, 128.9, 128.8, 128.2, 128.0, 127.6,
125.4, 122.0, 119.5, 114.4, 77.4, 76.7 ppm. HRMS found m/z
1011.2777; calcdm/z 1011.2786 for C58H38IrN8. UV-vis. (CHCl3) lmax
(ε/dm3 mol1 cm1): 554 (2100), 490 (3900), 415 (10700), 329
(24200), 286 (33200) nm. Selected IR (solid) ymax¼ 1607, 1445,
1350, 1253, 835, 760, 738, 696, 574, 557, 500, 468 cm1.
4.5.2. Synthesis of [Ir(L2)2(bipy)][PF6]
As [Ir(L1)2(bipy)][PF6] but with [(L2)2Ir(m-Cl2)Ir(L2)2] (56mg,
0.03mmol) and 2,20-bipyridyl (10mg, 0.07mmol). Product
collected as a red solid (44mg, 62%) 1H NMR (400MHz, CDCl3) dH
8.67 (d, J¼ 6.60 Hz, 2H), 8.59 (s, 2H), 8.53 (d, J¼ 8.8 Hz, 2H), 8.21
(dd, J¼ 7.72, 8.80 Hz, 2H), 7.98 (d, J¼ 8.80 Hz, 2H), 7.78 (m, 8H), 7.50
(m, 6H), 7.42 (app. t, J¼ 7.70, 2H), 7.24 (d, J¼ 7.72 Hz, 2H), 7.03 (d,
J¼ 7.72 Hz, 2H), 6.65 (d, J¼ 8.84 Hz, 2H), 6.43 (s, 2H), 2.57 (s, 6H),
1.94 (s, 6H) ppm. 13C{1H} NMR (101MHz, CDCl3) dC 164.8, 156.0,
148.0, 142.5, 141.7, 141.1, 140.5, 136.9, 136.3, 135.1, 134.0, 133.4, 132.3,
130.0, 129.1, 128.8, 128.5, 128.1, 128.0, 127.7, 127.5, 125.8, 123.8,
122.0, 21.8, 21.7 ppm. HRMS found m/z 1067.3406; calcd m/z
1067.3413 for C62H46IrN6. UV-vis. (CHCl3) lmax (ε/dm3mol1 cm1):
554 (2500), 491 (4900), 445 (9700), 420 (11000), 388 (14900), 367
(16900), 334 (28300), 283 (69500) nm. Selected IR (solid)
ymax¼ 1586, 1503, 1445, 1398, 1359, 1314, 1257, 1211, 1177, 1138,
1069, 1042, 978, 833, 772, 635, 579, 556, 513, 471, 424, 407 cm1.
4.5.3. Synthesis of [Ir(L3)2(bipy)][PF6]
As [Ir(L1)2(bipy)][PF6] but with [(L3)2Ir(m-Cl2)Ir(L3)2] (150mg,
0.06mmol) and 2,20-bipyridyl (20mg, 0.13mmol). Product
collected as a red solid (75mg, 61%). 1H NMR (400MHz, CDCl3) dH
8.82 (d, J¼ 8.80 Hz, 2H), 8.56 (s, 2H), 8.52 (d, J¼ 6.40 Hz, 2H), 8.21
(app. t, J¼ 8.40 Hz, 2H), 7.94 (d, J¼ 7.20 Hz, 3H), 7.77e7.68 (m, 5H),
7.62 (s, 2H), 7.49 (app. t, J¼ 8.40 Hz, 3H), 7.39 (app. t, J¼ 6.00 Hz,
3H), 7.11 (d, J¼ 7.20 Hz, 3H), 6.97 (m, 5H), 6.62 (s, 2H) ppm. 13C{1H}
NMR (101MHz, d6-acetone) dC 164.5, 155.8, 153.4, 149.6, 144.1,
141.0, 138.8, 137.5, 137.4, 136.8, 134.1, 133.7, 133.6, 132.3, 131.5, 129.3,
129.1, 128.5, 128.3, 127.9, 127.5, 126.5, 126.0, 124.8, 124.2, 122.4,
78.3 ppm. LRMS found m/z 1326.90; calcd m/z 1326.92 for
C58H34Br4IrN6. UV-vis. (CHCl3) lmax (ε/dm3 mol1 cm1): 554
(2400), 500 (5100), 439 (10700), 415 (11500), 340 (26000), 287
(34800) nm. Selected IR (solid) ymax¼ 1607, 1512, 1445, 1348, 1248,
1174, 1109, 1013, 878, 835, 760, 559, 500 cm1.
4.5.4. Synthesis of [Ir(L4)2(bipy)][PF6]
As [Ir(L1)2(bipy)][PF6] but with [(L4)2Ir(m-Cl2)Ir(L4)2] (100mg,
0.09mmol) and 2,20-bipyridyl (16mg, 0.11mmol). Product
collected as a red solid (27mg, 21%). 1H NMR (400MHz, CDCl3) dH
8.63 (d, J¼ 4.64 Hz, 2H), 8.45 (s, 2H), 8.43 (d, J¼ 8.00 Hz, 2H), 8.14
(app. t, J¼ 9.28 Hz, 2H), 7.87 (d, J¼ 8.12 Hz, 2H), 7.76 (m, 6H), 7.62 (s,
2H), 7.40 (dd, J¼ 6.96, 8.12 Hz, 2H), 7.32 (dd, J¼ 5.80, 9.28 Hz, 2H),
7.27 (s, 2H), 7.24 (s, 4H), 7.11 (d, J¼ 8.52 Hz, 2H), 6.94 (d, J¼ 8.16 Hz,
2H), 5.99 (s, 2H), 3.91 (s, 6H), 3.26 (s, 6H) ppm. 13C{1H} NMR
(101MHz, CDCl3) dC 164.2, 161.4, 156.0, 148.2, 141.1, 137.2, 136.7,136.2, 134.4, 134.0, 133.1132.1, 130.5, 128.9, 128.4, 128.1, 127.5, 125.6,
121.6, 119.8, 114.7, 108.3, 55.6, 54.8 ppm. HRMS found m/z
1131.3193; calcd m/z 1131.3209 for C62H46IrN6O4. UV-vis. (CHCl3)
lmax (ε/dm3 mol1 cm1): 554 (10000), 455 (31700), 348 (55200),
285 (120700) nm. Selected IR (solid) ymax¼ 1580, 1503, 1447, 1400,
1358, 1246, 1224, 1173, 1134, 1020, 978, 870, 837, 810, 772, 687, 519,
471 cm1.
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